Click here to download EHN's feedback to the Commission on strategic orientations and priorities for the 2023 EU4Health Work Programme.
In December 2021, the European Commission opened a consultation on Healthier Together, the EU non-communicable diseases initative. EHN submitted its views on priorities for the strands of cardiovascular disease and health determinants.
EHN submitted its views on the European Commission's public consultation aimed at evaluating the existing general pharmaceutical legislation on medicines for human use to support its revision to ensure a future-proof and crisis-resistant medicines regulatory system.
Click here to download EHN's feedback to the Commission's combined roadmap / inception impact assessment on the evaluation and revision of the general pharmaceutical legislation.
EHN responded to the Commission demand for feedback on EU farm and food products – review of policy on promotion inside and outside the EU
On this page, you can fin EHN's response to the public consultation on the Revision of Directive 2011/64/EU on the structure and rates of excise duty applied to manufactured tobacco
On this page, you can fin EHN's response to the public consultation on Cross-border acquisitions of excise goods by private individuals – revision of Article 32 of Directive 2008/118/EC
On this page, you can find EHN's response to the Commission's public consultation on the EU Strategy on the Rights of the Child (2021 - 2024). EHN's response focuses mainly on the aspect of marketing of unhealthy foods to children.
Please click here to download EHN's response to the Commission's public consultation on the Pharmaceutical Strategy - Timely patient access to affordable medicines.
On 18 september, EHN responded to the Commission's public consultation on Horizon Europe First Strategic Plan 2021-2024.
